| 01/26 | Piper Sandler Adjusts ShockWave Medical's Price Target to $280 From $300, Keeps Overwei.. | MT |
| 01/26 | Insider Sell: Penumbra | MT |
| 01/19 | NovoCure Appoints Chief Commercial Officer Pritesh Shah as Chief Growth Officer | MT |
| 01/19 | Novocure Announces Executive Changes | CI |
| 01/18 | Masimo, Philips Expand Technology Partnership | MT |
| 01/18 | Masimo and Philips Expand Partnership to Improve Telehealth for Patients and Clinicians.. | CI |
| 01/17 | Top Midday Gainers | MT |
| 01/17 | ShockWave Medical to Acquire Neovasc in Initial $100 Million Deal; Neovasc Shares Jump | MT |
| 01/17 | Shockwave Medical In Agreement to Acquire Neovasc | MT |
| 01/17 | Neovasc Inc., ShockWave Medical, Inc. - M&A Call | CI |
| 01/17 | Piper Sandler Adjusts NovoCure's Price Target to $80 From $70, Maintains Neutral Rating | MT |
| 01/17 | ShockWave Medical, Inc. Provides Earnings Guidance for the Fourth Quarter and Full Year.. | CI |
| 01/17 | Neovasc Brief: Shockwave Medical will acquire all outstanding Neovasc shar.. | MT |
| 01/17 | Neovasc Brief: Shockwave Medical Announcing Agreement to Acquire Neovasc | MT |
| 01/17 | ShockWave Medical, Inc. (NasdaqGS:SWAV) entered into a.. | CI |
| 01/11 | Sector Update: Tech Stocks Advancing During Wednesday Trading | MT |
| 01/11 | Sector Update: Tech Stocks Advancing Wednesday but Chipmakers Lag | MT |
| 01/11 | Transcript : Masimo Corporation Presents at 41st Annual J.P. Morgan Healthcar.. | CI |
| 01/11 | Sector Update: Tech | MT |
| 01/11 | Stifel Adjusts Price Target on Masimo to $170 From $164, Maintains Buy Rating | MT |
| 01/11 | Masimo Says US Judge Ruled Apple Infringed Its Pulse Oximeter Patent | MT |
| 01/11 | Sector Update: Health Care Stocks Flat to Higher Premarket Wednesday | MT |
| 01/11 | Fresh Inflation Data Eyed as Exchange-Traded Funds, Equity Futures Rise Pre-Bell Wednes.. | MT |
| 01/11 | Masimo Says US Judge Ruled Apple Infringed Its Pulse Oximeter Patent | MT |
| 01/11 | Insider Sell: Shockwave Medical | MT |
| 01/10 | U.S. judge rules Apple Watches infringed Masimo patent - medical device maker | RE |
| 01/10 | Transcript : NovoCure Limited Presents at 41st Annual J.P. Morgan Healthcare .. | CI |
| 01/10 | Penumbra, Inc. Launches Latest Innovation in Mechanical Thrombectomy, Lightning Flash | CI |
| 01/10 | Insider Sell: NovoCure | MT |
| 01/10 | Insider Sell: NovoCure | MT |
| 01/09 | NovoCure Reports Lower Q4, Higher 2022 Preliminary Revenue | MT |
| 01/09 | Transcript : Penumbra, Inc. Presents at 41st Annual J.P. Morgan Healthcare Co.. | CI |
| 01/09 | NovoCure Reports Lower Q4, Higher 2022 Preliminary Revenue | MT |
| 01/09 | Masimo Announces New Study Evaluates the Performance of Masimo Sphb Noninvasive Spot-Ch.. | CI |
| 01/06 | JPMorgan Adjusts NovoCure's Price Target to $99 From $86, Keeps Neutral Rating | MT |
| 01/06 | Morgan Stanley Adjusts Price Target on ShockWave Medical to $224 From $290, Maintains E.. | MT |
| 01/06 | Wells Fargo Downgrades NovoCure to Equalweight From Overweight, Adjusts Price Target to.. | MT |
| 01/06 | Tumor Treating Fields Study by Zai Lab’s Partner in Cancer Patients Reaches Prima.. | MT |
| 01/05 | Sector Update: Health Care Stocks Nudge Above Thursday Intra-Day Lows | MT |
| 01/05 | HC Wainwright Adjusts NovoCure's Price Target to $140 From $100, Maintains Buy Rating | MT |
| 01/05 | Sector Update: Health Care Stocks Struggling Thursday but Biotech Edging H.. | MT |
| 01/05 | Top Midday Gainers | MT |
| 01/05 | NovoCure, Zai Lab Study in Non-Small Cell Lung Cancer Meets Primary Endpoint'; Shares C.. | MT |
| 01/05 | Strong Labor Data in Spotlight After Hawkish Fed Minutes, US Equity Futures Turned Lowe.. | MT |
| 01/05 | NovoCure, Zai Lab Say Study of Non-Small Cell Lung Cancer Treatment Meets Primary Endpo.. | MT |
| 01/05 | Top Premarket Gainers | MT |
| 01/05 | Zai Lab Limited and Novocure Announce Pivotal Lunar Study in Non-Small Cell Lung Cancer.. | CI |
| 01/05 | Novocure Announces Pivotal Lunar Study in Non-Small Cell Lung Cancer Met Primary Overal.. | CI |
| 01/05 | Masimo Patient SafetyNet™ Helped Clinicians Reduce CPR Events and Rates, Improve C.. | CI |
| 01/03 | Masimo Announces New Prospective Study Evaluates the Accuracy of Masimo SpHb® Noninvasi.. | CI |
| 2022 | Insider Sell: Shockwave Medical | MT |
| 2022 | Truist Securities Adjusts Price Target on Penumbra to $255 From $228, Maintains Buy Rat.. | MT |
| 2022 | Medical device makers drop products as EU law sows chaos | RE |
| 2022 | Deutsche Bank Initiates Coverage on ShockWave Medical With Buy Rating, $285 Price Targe.. | MT |
| 2022 | BTIG Upgrades Masimo to Buy From Neutral With $180 Price Target | MT |
| 2022 | Masimo Issues Fiscal 2023 Outlook | MT |
| 2022 | Transcript : Masimo Corporation - Analyst/Investor Day | CI |
| 2022 | Masimo Announces Launch of the Expansion of the HEOS Platform to Provide Robust and Alw.. | CI |
| 2022 | ShockWave Medical Shares Drop After Wells Fargo Downgrade | MT |
| 2022 | Wells Fargo Adjusts Penumbra Price Target to $255 From $225, Maintains Overweight Ratin.. | MT |
| 2022 | Citigroup Adjusts Price Target on Penumbra to $270 From $212, Maintains Buy Rating | MT |
| 2022 | Wells Fargo Downgrades ShockWave Medical to Equalweight From Overweight, Lowers Price T.. | MT |
| 2022 | Masimo Corporation Announces Full Market Release of Hydration Index for the Masimo W1 A.. | CI |
| 2022 | Healthcare Company Getinge Signs Financing Partnership With BNP Paribas | MT |
| 2022 | BTIG Ups Price Target on Penumbra to $240 From $204, Reiterates Buy Rating | MT |
| 2022 | Needham Adjusts Masimo's Price Target to $173 From $149, Keeps Buy Rating | MT |
| 2022 | Transcript : NovoCure Limited Presents at Piper Sandler 34th Annual Healthcar.. | CI |
| 2022 | Transcript : ShockWave Medical, Inc. Presents at Piper Sandler 34th Annual He.. | CI |
| 2022 | Transcript : Masimo Corporation Presents at Piper Sandler 34th Annual Healthc.. | CI |
| 2022 | NovoCure Secures Health Canada's Approval for Optune to Treat Newly Diagnosed and Recur.. | MT |
| 2022 | Wells Fargo Upgrades NovoCure to Overweight From Equalweight, Adjusts Price Target to $.. | MT |
| 2022 | Insider Sell: Shockwave Medical | MT |
| 2022 | Transcript : Getinge AB - Special Call | CI |
| 2022 | U.S. Food and Drug Administration Broadens the Consent Decree with Getinge and Includes.. | CI |
| 2022 | Peer-Reviewed Study Finds That Masimo Set® Pulse Oximetry Has No Clinically Significant.. | CI |
| 2022 | Law firm Sidley warns clients about rules that may hinder activists | RE |
| 2022 | Masimo Shares Higher as Court Rules Former Executive Guilty of Stealing Trade Secrets | MT |
| 2022 | Insider Sell: Shockwave Medical | MT |
| 2022 | Insider Buy: Masimo | MT |
| 2022 | Insider Buy: Masimo | MT |
| 2022 | Transcript : Masimo Corporation Presents at Stifel 2022 Healthcare Conference.. | CI |
| 2022 | Penumbra, Inc. Launches First Hands-Free, Full Body Virtual Reality-Based Offering for .. | CI |
| 2022 | Novocure Opens Office in Montreal to Expand and Support Growing Business in Canada | CI |
| 2022 | Transcript : Penumbra, Inc. Presents at 13th Annual Jefferies London Healthca.. | CI |
| 2022 | Truist Securities Adjusts Penumbra Price Target to $228 From $200, Maintains Buy Rating | MT |
| 2022 | RBC Boosts Price Target on Penumbra to $215 From $195, Likes Positioning Into 2023; Kee.. | MT |
| 2022 | NovoCure Says it Will Initiate Limited Market Release of Transducer Array in Europe Aft.. | MT |
| 2022 | Piper Sandler Lowers Price Target on Masimo to $135 From $150, Maintains Neutral Rating | MT |
| 2022 | Tranche Update on Masimo Corporation's Equity Buyback Plan announced on August 9, 2022. | CI |
| 2022 | Masimo Posts Higher Fiscal Q3 Adjusted EPS, Revenue; Issues Fiscal Q4, Narrows FY Guida.. | MT |
| 2022 | Transcript : Masimo Corporation, Q3 2022 Earnings Call, Nov 08, 2022 | CI |
| 2022 | GUIDANCE: (MASI) MASIMO Expects Q4 EPS Range $1.11 - $1.22 | MT |
| 2022 | GUIDANCE: (MASI) MASIMO Expects Q4 Revenue Range $581M - $611M | MT |
| 2022 | Earnings Flash (MASI) MASIMO Reports Q3 Revenue $549.3M, vs. Street Est of $533.4M | MT |
| 2022 | Earnings Flash (MASI) MASIMO Reports Q3 EPS $1.00, vs. Street Est of $0.92 | MT |
| 2022 | Masimo Corporation Provides Earnings Guidance for the Fourth Quarter and Full Year of 2.. | CI |
| 2022 | Masimo Corporation Reports Earnings Results for the Third Quarter and Nine Months Ended.. | CI |
| 2022 | Wells Fargo Adjusts Price Target on ShockWave Medical to $300 From $255, Maintains Over.. | MT |
| 2022 | ShockWave Medical Earnings, Sales Increase in Q3; Lifts 2022 Revenue Guidance | MT |
| 2022 | Transcript : ShockWave Medical, Inc., Q3 2022 Earnings Call, Nov 07, 2022 | CI |
Google
Twitter
Facebook
Apple
English (UK)
English (Canada)
Deutsch (Deutschland)
Deutsch (Schweiz)
Español
Français (France)
Italiano
Nederlands (Nederland)
Nederlands (België)
Report
